Genetic study on Parkinson's disease and at-risk individuals
Part of Brain & nervous system clinical trials.
This trial studies genetic and biological samples from people with Parkinson's disease, their at-risk relatives, and healthy volunteers. It aims to find biomarkers that could help with earlier diagnosis and better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older).
- You must be part of the NS-PARK cohort – either as someone with Parkinson's disease, a family member or carrier of a Parkinson's-related gene, or a healthy control.
- If you are a woman who could become pregnant, you'll need a negative pregnancy test before joining.
- You must be covered by social security or entitled to benefits.
- You must not be pregnant or breastfeeding, and must not have any condition that makes a lumbar puncture (spinal tap) unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses digital tools and brain markers to detect Parkinson's disease early. It includes healthy people, those with early Parkinson's, and those with REM sleep behavior disorder (a possible early sign).
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
This study looks at early signs of brain diseases like Alzheimer's or Parkinson's before symptoms appear. It uses brain scans and blood tests to find markers that might help predict who will develop these conditions.
This study builds a genetics “registry” of people diagnosed with Parkinson’s disease who agree to genetic testing. Your information may help researchers understand why Parkinson’s happens and improve future treatments.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study collects blood and related samples to create a “biobank” and uses lab tests to study genetic risk in Parkinson’s disease and idiopathic REM sleep behavior disorder (RBD). It may help researchers understand why symptoms develop and improve future prevention or treatment approaches.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.